Corbus Pharmaceuticals Updates Executive Employment Agreements and Protections

Corbus Pharmaceuticals Holdings, Inc. (CRBP) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Corbus Pharmaceuticals Reports Q2 2026 Financial Results and Provides a Corporate Update • Obtained FDA clearance to proceed with registrational study (TEMPO-1) of CRB-701 in 2L oropharyngeal cancer and expect to initiate enrollment in September 2026 • Concluded last

Corbus Pharmaceuticals (CRBP) reported updated Phase 1/2 data for CRB-701 in 2L oropharyngeal and cervical cancers, based on an April 1, 2026 cut with 317 patients. It cited ORR of 42.9% (median DOR 6.3 months, PFS 5.6) in OPSCC and 34.4% (DOR 8.0, PFS 4.3) in cervical cancer. The company plans registrational trials starting with TEMPO-1 in summer 2026; shares were down 12.79% pre-market to $9.90.

AEVEX Corp. (NYSE: AVEX) faces a securities fraud class action lawsuit over alleged misstatements regarding a secondary public offering. The lawsuit covers investors who bought shares between April 17, 2026, and June 4, 2026. The stock dropped 16% on June 2, 2026, and 7% on June 5, 2026, following disclosures about the offering. Investors have until October 20, 2026, to seek lead plaintiff status.

The US State Department approved a $5 billion sale of Joint Direct Attack Munitions-Extend Range and a $750 million sale of AGT-1500 engines to Saudi Arabia. Boeing and Honeywell are the principal contractors, respectively. The sales aim to enhance Saudi Arabia's defense capabilities and regional interoperability, according to the State Department.

Guardant Health (GH) was ordered to pay $245.2M for patent infringement, with a 6% royalty on US sales of 11 products until 2033. The company plans to appeal, noting current versions of Reveal and Shield are excluded. The judgment includes $83.4M in damages, $19.5M in supplemental damages, $119.4M in royalties, and $22.9M in interest.

The U.S. State Department approved potential weapons sales to Saudi Arabia, including Joint Direct Attack Munitions for $5B and AGT-1500 engines for $750M. Boeing (BA) is involved in the deal.